Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
about
Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment.Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical validity of new genet ...... independent replication study.
@ast
Clinical validity of new genet ...... independent replication study.
@en
type
label
Clinical validity of new genet ...... independent replication study.
@ast
Clinical validity of new genet ...... independent replication study.
@en
prefLabel
Clinical validity of new genet ...... independent replication study.
@ast
Clinical validity of new genet ...... independent replication study.
@en
P2093
P2860
P356
P1476
Clinical validity of new genet ...... independent replication study
@en
P2093
A-J de Graan
F Innocenti
G L Rosner
M J Ratain
R H J Mathijssen
R H N van Schaik
P2860
P2888
P356
10.1038/TPJ.2015.23
P50
P577
2015-04-14T00:00:00Z